Allied Private Wealth’s Amgen AMGN Stock Holding History

Allied Private Wealth’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$148K	Buy	+402	New	+$138K	0.1%	141

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Allied Private Wealth's AMGN Position: Q2 2026 in Review

Allied Private Wealth opened a new position in Amgen (AMGN) in Q2 2026: 402 shares worth $148K. The stake represents 0.1% of the portfolio and ranks #141 among its holdings.

3,145 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Allied Private Wealth held 402 shares of Amgen worth $148K as of Q2 2026.
Amgen was a new Allied Private Wealth position in Q2 2026.
Amgen made up 0.1% of Allied Private Wealth's portfolio in Q2 2026, its #141 holding.
3,145 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Allied Private Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.